Search Advanced Search
Sign-up for Free Trial
Law360 - The Newswire for Business Lawyers
Subscribe | Sign In
Platform Tools
  • Cases
  • Tracking
  • News
  • Rankings
  • Jobs

Overall

All cases

Advanced search

Key cases

Class actions

Public companies

Industries

Banking & finance

Consumer goods

Health

Hospitality

Life sciences

Media & entertainment

Oil & gas

Retail

Technology

Intellectual Property

Copyright

Patent

Trademark

Labor & Employment

Employment class actions

Discrimination

ERISA

Labor/management

Corporate

Antitrust

Bankruptcy appeals

Commercial contracts

Environmental

Insurance

Product liability

Real estate

Securities

Tax

Practice Areas

Appellate

Bankruptcy

Class Action

Commercial Contracts

Competition

Corporate

Employment

Environmental

Government Contracts

Insurance

Intellectual Property

International Trade

Mergers & Acquisitions

Privacy

Product Liability

Project Finance

Public Policy

Securities

White Collar

Industries

Banking

Energy

Health

Life Sciences

Media & Entertainment

Private Equity

Real Estate

Technology

Regions

California

Florida

New Jersey

New York

Pennsylvania

Texas

Legal Industry

Law Firms

Companies

Industries

Government Agencies

FCPA Powerhouses

Global 20

Innovative Managing Partners

MVPs of the Year

Practice Groups of the Year

Pro Bono Firms of the Year

Rising Stars

Top Female Trial Attorneys

E-mail Report on Par Pharmaceutical Com...
Healthcare » Drugs - Generic » Par Pharmaceutical Companies, Inc.

Par Pharmaceutical Companies, Inc.

  • Everything »
  • News & Analysis »
  • New Cases »
  • Case Activity »
  • Outside Counsel »

Data on cases, clients, outside counsel and individual attorneys collected from active federal civil cases. Reflects only recently published court data; not intended to be exhaustive. Not responsible for errors in court dockets.

News (219)

  1. June 17, 2013 FTC Fought Long, Hard Battle Against Pay-For-Delay Deals

    ... Pharmaceuticals Inc. — now Actavis Inc. — and Par Pharmaceutical Companies Inc. in February 2009. But...

  2. June 17, 2013 High Court Brings Economics Back To Pay-For-Delay Analysis

    ... Defendant-Appellant, versus Watson Pharmaceuticals Inc. Solvay Pharmaceuticals Inc. Defendants-Appellees, Par...

  3. June 17, 2013 Pay-For-Delay Deals Can Be Illegal, Justices Rule

    ... Par Pharmaceutical Cos. are anti-competitive under the antitrust laws. But the ruling also falls short...

Cases (82)

  1. May 15, 2013 | New York Southern | Added May 15, 2013 Endo Pharmaceuticals, Inc. v. Par Pharmaceutical Companies, Inc. et al

    Patent

  2. May 14, 2013 | Delaware | Added May 14, 2013 Bayer Pharma AG et al v. Par Pharmaceutical Inc. et al

    830(Patent)

  3. April 26, 2013 | California Northern | Added April 26, 2013 Par Pharmaceutical, Inc. et al v. Takeda Pharmaceutical Co., Ltd. et al

    830(Patent)

  4. 79 additional result(s)
To view all the results and drill down deeper, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Register

© Copyright 2013, Portfolio Media, Inc. | Home | About | Contact Us | Site Map | Site Index | Jobs | Careers at Law360 | Mobile | Terms

Track docs | Track attorneys | Track judges